Debio 0123 in combination with carboplatin and etoposide in adult participants with small cell lung cancer that recurred or progressed after platinum-based therapy.
Debio 0123-SCLC-104
Phase 1 other active
Quick answer
Debio 0123 in combination with carboplatin and etoposide in adult participants with small cell lung cancer that recurred or progressed after platinum-based therapy. for Small cell lung cancer is a Phase 1 program (other) at Pharm Research Associates (UK) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharm Research Associates (UK) Limited
- Indication
- Small cell lung cancer
- Phase
- Phase 1
- Modality
- other
- Status
- active